CHARLES M. BAUM - 04 Jan 2022 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
President,Founder,Head of R&D, Director
Signature
/s/ Vickie Reed, Attorney-in-Fact
Issuer symbol
MRTX
Transactions as of
04 Jan 2022
Transactions value $
-$607,855
Form type
4
Filing time
06 Jan 2022, 15:51:29 UTC
Previous filing
17 Dec 2021
Next filing
18 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$598K -4.05K -3.84% $147.73 101K 04 Jan 2022 Direct F1
transaction MRTX Common Stock Sale -$10.3K -69 -0.07% $149.09 101K 04 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 3, 2020.